EIE-European innovation ecosystems

600m people globally suffer from autoimmune diseases such as rheumatoid arthritis (RA), psoriasis, and multiple sclerosis. The symptoms can be severe, causing intense pain and suffering for patients. The cost of RA alone for Europe is €45.3 billion p.a. A growing need: Unlike diabetes patients for example who can measure their own blood sugar levels, there is currently no method to measure disease activity quickly and accurately for autoimmune patients, non-invasively at home. Furthermore, most autoimmune diseases have unpredictable flares in disease activity despite stable medication, and the causes of such flares differ between patients and are largely unidentifiable. Our deep-tech innovation is an Artificial Intelligence approach to the Monitoring of Autoimmune Diseases at Home with a Novel Biomarker Algorithm: Through 15 years of research in this field, the founder of Kaass Discovery, Dr Anita Kaass, has shown a key biomarker, Gonadotropin releasing hormone (GnRH), is common to several autoimmune diseases. It has been scientifically shown that GnRH levels increase with increasing disease activity. Kaass Discovery is developing a highly novel, deep tech solution to allow autoimmune disease patients to self-manage their conditions and minimize or even eliminate the symptoms of autoimmune diseases. The solution, which we call ‘a-Doc’, uses a saliva sample to indicate disease activity and provide an accurate, instantaneous value. In line with this need, it is also low cost, accurate and simple to use ensuring it is suitable for home use. The data collected from the device will be sent to the Kaass Discovery Cloud for improving the predictive analytical models, and giving an individualised meaningful result to the user on their mobile device The aims of the Women TechEU programme align perfectly with the needs of Kaass Discovery. The business coaching support provided will ensure we are prepared and able to successfully commercialise this exciting technology.

Funding scheme:

EIE-European innovation ecosystems

87.7MILL. NOKtotal funding in the programme period 8PROJECTShave received funding in the programme period 1SOURCEhas financed the programme

Funding Sources

Thematic Areas and Topics

Internasjonalisering Industri og tjenester Industri og tjenestenæringer Helsenæringen Politikk- og forvaltningsområder Helse og omsorg Forskningsinfrastruktur Politikk- og forvaltningsområder LTP3 Muliggjørende og industrielle teknologier Portefølje Forskningssystemet LTP3 Nano-, bioteknologi og teknologikonvergens Muliggjørende teknologier Innovasjon i offentlig sektor Helse og omsorg Industri og tjenestenæringer Kommersialisering Innovasjon Helse og omsorg Landbasert mat, miljø og bioressurser Bioteknologi Portefølje Muliggjørende teknologier LTP3 Styrket konkurransekraft og innovasjonsevne Bransjer og næringer Helsenæringen Innovasjon Næring og handel Innovasjon i offentlig sektor Næring og handel LTP3 Uttesting og kommersialisering av FoU Forskningsinfrastruktur Bioteknologi Bransjer og næringer Anvendt forskning Politikk- og forvaltningsområder Næring og handel Internasjonalisering Internasjonalt prosjektsamarbeid Industri og tjenestenæringer Bioteknologi Landbasert mat, miljø og bioressurser Muliggjørende teknologier Bioteknologi LTP3 Et kunnskapsintensivt næringsliv i hele landet Industri og tjenester Bioteknologi Bioteknologi Medisinsk bioteknologi Portefølje Innovasjon Bioteknologi

EIE-European innovation ecosystems

Intelligent Personalised Disease Monitoring Device: a-Doc

Awarded: NOK 0.76 mill.

Popular Science Description

Summary

Funding scheme:

EIE-European innovation ecosystems

Funding Sources

Thematic Areas and Topics